Urografin® (Sodium Amidotrizoate / Amidotrizoate Meglumine)

Urografin^® Product Information (PI)

View PI

Urografin^® Consumer Medicine Information (CMI)

View CMI

Bayer reserves the right to modify the specifications and features described herein or to discontinue any product or service identified in this publication at any time without prior notice or obligation. Please contact your authorised Bayer representative for the most current information.

For Medical Information relating to medicines please contact our Medical department at medinfo.anz@bayer.com or on 1800 008 757 (AU).
For medical inquiries relating to devices please contact your local Bayer representative.

Report Adverse Events
If you want to report an adverse event for medicines or devices, please contact your healthcare professional (e.g. physician or pharmacist) or the Therapeutic Goods Administration (TGA). Details on how to report to the TGA can be found at https://www.tga.gov.au/reporting-problems

Adverse events for medicines should also be reported to Bayer via email to drugsafety.anz@bayer.com or by phoning 1800 008 757.
Adverse events for devices should also be reported to Bayer via email to ricustomercomplaints@bayer.com

If you want to report a Quality Complaint
If you want to report a medicine quality complaint please contact drugsafety.anz@bayer.com
If you want to report a device quality complaint please contact ricustomercomplaints@bayer.com

Radiology
Bayer Australia Ltd
875 Pacific Highway, Pymble NSW 2073
ABN 22 000 138 714

PP-PF-RAD-AU-0062-1

Date of Preparation October 2021